HOXA9 inhibitors promote microcirculation of coronary arteries in rats via downregulating E‑selectin/VCAM‑1

Liu,Shilei; Gao,Jing; Wang,Sai

doi:10.3892/etm.2021.10303

HOXA9 inhibitors promote microcirculation of coronary arteries in rats via downregulating E‑selectin/VCAM‑1

Authors:
- Shilei Liu
- Jing Gao
- Sai Wang
View Affiliations

Affiliations: Internal Medicine‑Cardiovascular Department, Shengli Oilfield Central Hospital, Dongying, Shandong 257000, P.R. China
Published online on: June 13, 2021 https://doi.org/10.3892/etm.2021.10303
Article Number: 871
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atherosclerosis (AS) is a chronic pathophysiological process that causes high mortality and morbidity. It has previously been reported that homeobox A9 (HOXA9) may participate in regulation of the cardiovascular system and the pathology of AS by upregulating E‑selectin and vascular cell adhesion molecule‑1 (VCAM‑1). Thus, inhibiting HOXA9 could promote microcirculation of coronary arteries and could act as a potential therapy for AS treatment. Sprague‑Dawley rats were randomly divided into four groups, as follows: i) AS; ii) AS + HOXA9 inhibitor; iii) AS + small interfering RNA‑HOXA9 and iv) normal control. ELISA was used to measure the levels of TNF‑α, IL‑1β, IL‑12, C‑C motif chemokine ligand 25 (CCL25), low‑density lipoprotein (LDL), high‑density lipoprotein (HDL) and very‑low‑density lipoprotein (VLDL). Flow cytometry was employed to detect the content of M1 macrophages. Hematoxylin & eosin (H&E) staining was performed to observe the morphology of the coronary arteries. Oil red O staining was conducted for the evaluation of lipid accumulation. Immunohistochemistry was used to visualize the protein expression levels of HOXA9 in the coronary arteries. Western blotting was utilized to determine the protein expression levels of HOXA9, platelet factor‑4 (PF4), E‑selectin and VCAM‑1. HOXA9 inhibitors were found to downregulate the levels of TNF‑α, IL‑1β, IL‑12, CCL25, LDL and VLDL, and upregulate HDL levels in the blood of AS rats. The content of M1 macrophages was also decreased following injection of HOXA9 inhibitors in the AS group. H&E and oil red O staining analysis indicated that HOXA9 inhibitors attenuated vascular symptoms and lipid formation in AS rats. Furthermore, western blotting suggested that inhibition of HOXA9 reduced the expression levels of PF4, E‑selectin and VCAM‑1, while overexpression of PF4 resulted in the opposite effects. The present study revealed that inhibiting HOXA9 alleviated the symptoms of AS via downregulation of the PF4 and E‑selectin/VCAM‑1 pathway to promote microcirculation in the coronary arteries of AS rats. These findings indicated that HOXA9 inhibitors may have the potential to succeed in the treatment of AS.

View Figures

View References

1	Libby P, Lichtman AH and Hansson GK: Immune effector mechanisms implicated in atherosclerosis: From mice to humans. Immunity. 38:1092–1104. 2013.PubMed/NCBI View Article : Google Scholar
2	Kwon GP, Schroeder JL, Amar MJ, Remaley AT and Balaban RS: Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points. Circulation. 117:2919–2927. 2008.PubMed/NCBI View Article : Google Scholar
3	Bäck M and Hansson GK: Anti-inflammatory therapies for atherosclerosis. Nat Rev Cardiol. 12:199–211. 2015.PubMed/NCBI View Article : Google Scholar
4	Herrero-Fernandez B, Gomez-Bris R, Somovilla-Crespo B and Gonzalez-Granado JM: Immunobiology of atherosclerosis: A complex net of interactions. Int J Mol Sci. 20(5293)2019.PubMed/NCBI View Article : Google Scholar
5	Gimbrone MA Jr and García-Cardeña G: Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 118:620–636. 2016.PubMed/NCBI View Article : Google Scholar
6	Barrett TJ: Macrophages in atherosclerosis regression. Arterioscler Thromb Vasc Biol. 40:20–33. 2020.PubMed/NCBI View Article : Google Scholar
7	Chistiakov DA, Orekhov AN and Bobryshev YV: Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol. 6(365)2015.PubMed/NCBI View Article : Google Scholar
8	Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV and Orekhov AN: Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl). 95:1153–1165. 2017.PubMed/NCBI View Article : Google Scholar
9	Bakogiannis C, Sachse M, Stamatelopoulos K and Stellos K: Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 122(154157)2019.PubMed/NCBI View Article : Google Scholar
10	Iademarco MF, Barks JL and Dean DC: Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest. 95:264–271. 1995.PubMed/NCBI View Article : Google Scholar
11	Cantile M, Schiavo G, Terracciano L and Cillo C: Homeobox genes in normal and abnormal vasculogenesis. Nutr Metab Cardiovasc Dis. 18:651–658. 2008.PubMed/NCBI View Article : Google Scholar
12	Duboule D and Morata G: Colinearity and functional hierarchy among genes of the homeotic complexes. Trends Genet. 10:358–364. 1994.PubMed/NCBI View Article : Google Scholar
13	Gorski DH and Walsh K: The role of homeobox genes in vascular remodeling and angiogenesis. Circ Res. 87:865–872. 2000.PubMed/NCBI View Article : Google Scholar
14	Bandyopadhyay S, Ashraf MZ, Daher P, Howe PH and DiCorleto PE: HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells. Mol Cell Biol. 27:4207–4216. 2007.PubMed/NCBI View Article : Google Scholar
15	Pang J, Xu Q, Xu X, Yin H, Xu R, Guo S, Hao W, Wang L, Chen C and Cao JM: Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat. Peptides. 31:630–638. 2010.PubMed/NCBI View Article : Google Scholar
16	Zheng X and Hu X: Effects of rosuvastatin on hypertension with carotid atherosclerosis and its influence on peripheral macrophage polarization. Chinese Journal of Clinical Pharmacology and Therapeutics. 22:1035–1039. 2017.
17	Wang J, Hou J, Lin C, Fu J, Ren J, Li L, Guo H, Han X, Wang B and Liu J: Shuangshen ningxin capsule, a traditional Chinese medicinal preparation, alleviates myocardial ischemia through autophagy regulation. Evid Based Complement Alternat Med. 2015(581260)2015.PubMed/NCBI View Article : Google Scholar
18	Xu B, Geerts D, Bu Z, Ai J, Jin L, Li Y, Zhang H and Zhu G: Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes. Hum Reprod. 29:781–790. 2014.PubMed/NCBI View Article : Google Scholar
19	Sun X, He S, Wara AKM, Icli B, Shvartz E, Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, et al: Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res. 114:32–40. 2014.PubMed/NCBI View Article : Google Scholar
20	Shirai T, Hilhorst M, Harrison DG, Goronzy JJ and Weyand CM: Macrophages in vascular inflammation-From atherosclerosis to vasculitis. Autoimmunity. 48:139–151. 2015.PubMed/NCBI View Article : Google Scholar
21	Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou A and Koutsilieris M: Vitamin D in cardiovascular disease. In Vivo. 32:977–981. 2018.PubMed/NCBI View Article : Google Scholar
22	Xie W, Li L, Zhang M, Cheng HP, Gong D, Lv YC, Yao F, He PP, Ouyang XP, Lan G, et al: MicroRNA-27 prevents atherosclerosis by suppressing lipoprotein lipase-induced lipid accumulation and inflammatory response in apolipoprotein E knockout mice. PLoS One. 11(e0157085)2016.PubMed/NCBI View Article : Google Scholar
23	Calvo KR, Sykes DB, Pasillas M and Kamps MP: Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol. 20:3274–3285. 2000.PubMed/NCBI View Article : Google Scholar
24	Trivedi CM, Patel RC and Patel CV: Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis. 195:e50–e60. 2007.PubMed/NCBI View Article : Google Scholar
25	Xuan W, Qu Q, Zheng B, Xiong S and Fan GH: The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 97:61–69. 2015.PubMed/NCBI View Article : Google Scholar
26	Li W, Tang C, Jin H and Du J: Effects of onion extract on endogenous vascular H2S and adrenomedulin in rat atherosclerosis. Curr Pharm Biotechnol. 12:1427–1439. 2011.PubMed/NCBI View Article : Google Scholar
27	Domschke G and Gleissner CA: CXCL4-induced macrophages in human atherosclerosis. Cytokine. 122(154141)2019.PubMed/NCBI View Article : Google Scholar
28	Jiang Y, Jiang LL, Maimaitirexiati XM, Zhang Y and Wu L: Irbesartan attenuates TNF-α-induced ICAM-1, VCAM-1, and E-selectin expression through suppression of NF-κB pathway in HUVECs. Eur Rev Med Pharmacol Sci. 19:3295–3302. 2015.PubMed/NCBI
29	Shih MF, Pan KH, Liu CC, Shen CR and Cherng JY: Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression. Regul Toxicol Pharmacol. 92:333–337. 2018.PubMed/NCBI View Article : Google Scholar